Biological signaling networks process extracellular cues to control important cell decisions such as death-survival, growth-quiescence, and proliferation-differentiation. After receptor activation, intracellular signaling proteins change in abundance, modification state, and enzymatic activity. Many of the proteins in signaling networks have been identified, but it is not known how signaling molecules work together to control cell decisions. To begin to address this issue, we report the use of partial least squares regression as an analytical method to glean signal-response relationships from heterogeneous multivariate signaling data collected from HT-29 human colon carcinoma cells stimulated to undergo programmed cell death. By partial least squares modeling, we relate dynamic and quantitative measurements of 20-30 intracellular signals to cell survival after treatment with tumor necrosis factor alpha (a death factor) and insulin (a survival factor). We find that partial least squares models can distinguish highly informative signals from redundant uninformative signals to generate a reduced model that retains key signaling features and signal-response relationships. In these models, measurements of biochemical characteristics, based on very different techniques (Western blots, kinase assays, etc.), are grouped together as covariates, showing that heterogenous data have been effectively fused. Importantly, informative protein predictors of cell responses are always multivariate, demonstrating the multicomponent nature of the decision process.
INTRODUCTION T
he response of cells to cytokines, growth factors, and hormones is mediated by receptors that transduce extracellular cues into changes in intracellular physiology. Downstream of receptors, signal (a) Schematic illustration of the biomolecular signaling network governing cell death-versus-survival decisions in response to prodeath cues (TNF-α) and prosurvival cues (insulin) (Janes et al., 2003) . Network state is determined by many component characteristics, including protein expression levels, protein-protein interactions, protein enzymatic activities, and protein locations. Approximately 30 of these characteristics are measured in quantitative and dynamic terms for multivariate systems analysis. Green arrows indicate activating interactions, red arrows indicate inhibitory interactions, and blue arrows indicate transcriptional interactions. Shaded nodes highlight proteins whose characteristics were measured experimentally. Diagram is not implied to be comprehensive (e.g., location-dependent interactions have been abstracted). (b) Spectrum of computational approaches for modeling protein networks: clustering (Rives et al., 2003) , partial least squares, Markov models (Gomez et al., 2002) , Bayesian networks (Sachs et al., 2002) , Boolean networks (Huang et al., 2000) , and differential equations (Schoeberl et al., 2002) . The spectrum is not implied to be comprehensive.
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MATERIALS AND METHODS
Cell culture and treatment
HT-29 cells (ATCC) were grown in McCoy's 5A medium, supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 Units/ml penicillin, and 100 µg/ml streptomycin (Invitrogen). For signaling experiments, cells were seeded at 50,000 cells/cm 2 , grown for 24 h and then treated in complete medium supplemented with 200 U/ml interferon gamma (IFNγ , Roche) for an additional 24 h. After sensitization in medium with IFNγ , cells were rinsed once with medium and treated with complete medium supplemented with 50 ng/ml TNF-α (Peprotech) with or without 100 nM insulin (Roche) for the indicated time.
For cell death experiments, HT-29 cells were seeded at 1.6 × 10 4 per well in 96-well plates. After 24 hours of growth, the cells were treated with IFNγ for 25 hours. Pretreatment with the inhibitors (50, 16.7, 5.6 , or 1.8 µM PD98059; 1000, 333, 111, or 37 nM wortmannin; 10, 3.3, 1.1, or 0.37 µM SB203580; 10, 3.3, 1.1, or 0.37 µM SP600125; and combinations thereof) was performed during the final 90 minutes of IFNγ stimulation. After removal of the pretreatment medium, the cells were treated with the same inhibitors as during the pretreatment, in medium alone or in the presence of 50 ng/ml TNF-α or 50 ng/ml TNF-α + 50 nM insulin.
Quantitative Western blot assay
Whole cell lysates of both adherent and nonadherent cells were prepared in 125 mM Tris-HCl pH 6.8, 4% SDS, 20% glycerol, 10 mM NaF, 10 mM Na 4 P 2 O 7 , 10 mM β-glycerophosphate, 1 mM Na 3 VO 4 , 10 µg/ml leupeptin, 10 µg/ml pepstatin, and 10 µg/ml chymostatin. Protein concentration was determined by the bicinchoninic acid assay (Pierce). Proteins (50 µg of lysate) were separated by SDS-PAGE and then transferred to nitrocellulose. After blocking (30-60 min at room temperature), blots were probed overnight at 4 • C in primary antibody, washed 3 × 5 min in TBS-T (20 mM Tris-HCl pH 7.5, 137 mM NaCl, 0.1% Tween 20), incubated 1 h at room temperature in secondary antibody (1:2500 Alexa-488 conjugated goat anti-rabbit or 1:2500 phycoerythrin-conjugated goat anti-mouse, Pierce), and finally washed 3 × 5 min in TBS-T. Blots were scanned on a FluorImager 495 (Molecular Dynamics) and quantitated using ImageQuant 5.0 software (Molecular Dynamics). Primary antibodies used were anti-phospho-Akt substrates (1:1000), anti-Akt, anti-phospho-Akt (S473, 1:1000), anti-caspase-8 (1C12, 1:1000), anti-phospho-FKHR and AFX (S256, 1:1000), anti-phospho-IκB-α (S32, 1:500), anti-MEK1/2 (1:1000), anti-phospho-MEK1/2 (S217/221, 1:1000), anti-phospho-SAPK/JNK (T183/Y185, 1:500), anti-caspase-3 (1:500), anti-cleaved caspase-3 (1:1000) (Cell Signaling Technology), and anti-TNFR1 (1:1000, Biovision). Data points are averages of two independent time courses.
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SIMCA-P 10.0 (Umetrics) software suite according to the following iterative formula:
where E i represents the residual of the i th principal component, with score vector t i and loading vector p i , and T represents transpose. The information captured by the i th component was determined by the following formula:
For the discriminant PLS regression (DPLSR) model, a binary approach was used to generate a dependent block classifying TNF-α (≡ 0)-and TNF-α + insulin (≡ 1)-treated samples. DPLSR was done in SIMCA-P according to (1) for the independent block and the following iterative formula for the dependent (Y) block:
where F i represents the residuals of the i th dependent principal component, with score vector t i and loading vector q i , and b i represents the weight characterizing the inner relation between the independent and dependent principal components. The class structure captured by the i th component was determined by the following formula:
A block shuffling algorithm was programmed in MATLAB (Mathworks Inc.) to determine the regression coefficients that were significant in predicting the dependent variables in these models: the dependent block was randomized, and then PLS analysis was conducted via the NIPALS algorithm (Geladi et al., 1986) using a PLS Toolbox (Eigenvector Research). The results of 500 shuffling iterations were recorded, and the mean ± S.D. was reported. Regression coefficients greater than one S.D. outside of the shuffling iterations were considered significant.
For the inhibitor datasets, the effects of the pharmacological inhibitors on kinase activity could not be experimentally measured. Instead, approximate activities using the known in vivo IC 50 values of the various inhibitors (Alessi et al., 1995; Arcaro et al., 1993; Bennett et al., 2001; Cuenda et al., 1995) were derived and scaled to values from zero (complete inhibition) to one (no inhibitor) for each kinase. When the estimated ERK, JNK, p38, and PI3K activities were cast as a four-dimensional signaling space and a one-dimensional response space of measured levels of apoptosis, the problem was not well posed for PLS analysis, because little insight was gained by reducing four dimensions to two or three. (PLS models are most useful for data reduction when the original signaling space exceeds 10 measurements [K.A.J., unpublished observations].) To address this issue (and to include that certain kinase activities might have nonadditive effects on cell survival), two-factor (Signal 1 × Signal 2), square (Signal 1 × Signal 1), and cubic terms were appended to the independent block of calculated activities, and the expanded measurement set was analyzed with the same iterative formula as the DPLSR approach.
RESULTS AND DISCUSSION
Directed data acquisition and biological significance
To generate models, PLS relies on a data matrix of informative, quantitative measurements. Our work focuses on the regulation of programmed cell death in response to the prodeath factor TNF-α and the survival factor insulin. We directed our experimental measurements to a subset of the downstream kinases, caspases, and other regulators that are known to influence cell death or survival ( Fig. 1(a) ). In particular, we focused on those proteins whose signaling varies in response to TNF-α, insulin, or both, and whose perturbation, by genetic or other means, affects cell survival. By imposing both these criteria, we increase the likelihood that the data we collect will make a useful contribution to models of apoptotic signaling.
In our experimental analysis of apoptosis, we have examined four types of protein-based signals: phosphorylation, enzymatic activity, abundance, and cleavage state. Protein phosphorylation is an important mechanism of signal transduction in cells (Hunter, 2000) , and measurements of the phosphorylation states of signaling proteins and the enzymatic activity of the protein kinases that catalyze these phosphorylation events represent one source of information on death and survival signals. Similarly, measurement of protein abundance captures important information on both intracellular signaling proteins and cytokine receptors. Finally, measurement of the cleavage states of caspases, the biochemical executors of apoptosis (Nicholson et al., 1997) , makes it possible to gauge how far cells have progressed towards death.
The specific data points collected in this paper come from three types of measurements, which each characterize one or more of these four types of signals. In one set of data, we explored signaling dynamics in depth by quantifying nearly 30 protein states, levels of abundance, and activity from HT-29 cells treated with 50 ng/ml TNF-α alone or in combination with 100 nM insulin at various time points subsequent to cytokine addition (Fig. 2) . The kinase activities of five protein kinases (ERK, Akt, JNK, IKK, and MK2) were measured with a kinase activity assay (Fig. 2(c-d) ) (Janes et al., 2003) , in which kinases are immunoprecipitated from cells and mixed with protein or peptide substrates. Three of these kinases (ERK, MK2, and JNK) are components of mitogen-activated protein kinase cascades, Akt is a key mediator of survival signals, and IKK regulates the nuclear factor-κB transcription factor ( Fig. 1(a) ). Regulatory phosphorylation events were monitored for MEK, Akt, and JNK by Western blotting (Fig. 2(a-b) ). Western blotting was also used to examine the phosphorylation of several Akt and IKK substrates, as well as the cleavage state of caspase 8 and the executioner caspase, caspase 3. One important feature of the measurements is that they yield heterogeneous data with regard to experimental technique and biological significance. In spite of this heterogeneity, the data all capture signals that meet the criteria for multivariate analysis: signals that vary in response to cues and signals that, when perturbed, affect cell response.
In another set of experiments, the apoptotic response of HT-29 cells was measured in the presence of different small molecule kinase inhibitors that act as drugs. By examining the combinatorial effects of these molecular-level perturbations on cell survival, we indirectly explored signal-response relationships and broadly surveyed the quantitative range of the apoptotic response in HT-29 cells. For these experiments, changes in apoptosis were measured by flow cytometry with an apoptotic marker: caspase-cleaved cytokeratin.
Compact representations of signaling by principal component analysis
As a first approach to reducing the complexity of our data, we used principal component analysis (PCA), a nondirected multivariate analysis technique. We cast our data as a matrix of M rows, representing m i experimental samples, and N columns, representing n i measurements on the experimental samples. For multivariate analysis to work most effectively, this matrix should have as few empty elements as possible, implying that the same measurements be performed on all samples.
Here, all 29 measurements were performed on all 26 samples (13 time points per treatment × 2 treatments), leaving no empty elements in the data matrix. The different time points were collected from separate tissue culture plates, so the individual time points from both treatments were blindly considered as independent samples for the purposes of the multivariate analysis. Since all of the measurements were made on samples prepared under identical conditions, we can safely include these in the same sample row. However, not all measurements used the same cell extract material (since the different assays require different extract procedures; see Materials and Methods), so it is possible that some of the variation in the measurements might be due to variability in the lysate preparations.
An M × N matrix is frequently viewed as a flat, two-dimensional spreadsheet of numbers; alternatively, the data can be thought to represent a multidimensional "signaling" space, where the different protein measurements form a set of N axes (Fig. 3 ). The M samples are then vectors describing coordinates in the N-dimensional space, such that the projection of a sample vector m i on to axis n i represents one measurement. In this N -dimensional space, the axes are not orthogonal, meaning that the measurements defining these axes are partially redundant. Moreover, the m i sample vectors project on some axes more than others, because some measurements have a wider range of variation than others.
PCA reduces the dimensionality of the data space and the size of the M × N matrix, by factoring it into the product of an M × P scores matrix, containing the same number of scores as samples in the data, and a P × N loadings matrix, containing the same number of loadings as original measurements. (a) and (c)) or both 50 ng/ml TNF-α and 100 nM insulin ((b) and (d)). For (a) and (b), "P-" signifies phosphorylation state. Note the difference in scale between (a-b) and (c-d). Activity measurements are reprinted from Janes et al., (2003) with permission.
FIG. 3.
A data matrix of N signaling measurements can be represented as an N-dimensional signaling space and reduced via principal components analysis to a P -dimensional principal component space. Column shade represents the magnitude of the measurement in the different samples. Note the colinearity of axes in signaling space and the orthogonality of axes in principal component space.
This decomposition represents the data in P dimensions, with p i principal components, or latent variables, of the system. These principal components form a new, orthogonal coordinate system. The scores matrix defines how far the samples project along the coordinate system of the p i principal components, and the loadings matrix defines how the principal component axes "point" relative to the original measurement space. These two matrices enable one to flip from principal component space to signaling space, and vice versa, by matrix multiplication and division, respectively. The multiplication of a row in the scores matrix and a column in the loadings matrix is called an outer product. Most computational algorithms determine the principal components iteratively, with the first component capturing as much of the measurement information (i.e., the changes in measurement values over all samples) as possible. Then, the outer product of the first score-loading vector pair is subtracted from the original data matrix, and the second principal component is calculated to capture as much of the residual information as possible. To avoid biasing the decomposition toward measurements with disproportionately large absolute magnitudes or dynamic ranges, we subtract the mean of each measurement, taken across all samples, and divide by the measurement variance. These preprocessing techniques (called mean centering and variance scaling, respectively) eliminate difficulties associated with measurement heterogeneity by putting all data evenly on a unitless measurement axis with a mean of zero and variance of one. This enables scale-free, intermeasurement comparisons in the decomposition procedure.
If the data matrix is completely decomposed by iteration, then P will equal the lesser of M and N , and the product of the scores and loadings matrices will exactly equal the original dataset. However, because the principal components were iteratively calculated to maximize information capture, good approximations of the original dataset can be obtained with only the first few principal components. In this way, PCA generates a data-driven model, comprised of the most significant principal components, and extracts the most salient features of a dataset while removing spurious fluctuations (usually from measurement error and noise). The critical question in PCA is whether a significant fraction of the measurement information (≥ 60%) can be captured effectively when P is much less than N .
To begin to determine the most critical factors in our dataset for influencing the death-versus-survival decision, we performed PCA on a complete set of preprocessed protein data and examined the amount of information captured as a function of increasing principal component number. In Fig. 4(a) , we see that the first two principal components together capture over 62% of the information in the original data matrix, with progressively smaller contributions from higher dimensions. Often with PCA, the residual information from higher components (in this model, 38% of the total) is postulated to contain mostly random experimental fluctuations. However, with only 29 measurements, our sample set was too small to permit a rigorous treatment of signal to noise (see Fig. 4(a) legend) . Therefore, we further examined the quality of the two-component PCA model by plotting how the different samples mapped along the two principal components via their scores (Fig. 4(b) ). The size of the data markers represents increasing time; we see that that earlier time points fall largely south and southeast on the two principal components in Fig. 4(b) , whereas later time points are located more north and northwest. Importantly, when we applied an objective test to the TNF-α (diamonds) and TNF-α + insulin (squares) time courses, we found that the two sets of measurements were separated in a highly significant fashion, with p < 0.005 that the data represents two distinct populations by a two-dimensional Kolmogorov-Smirnov test (Fasano et al., 1987) , illustrated schematically by the hatched line in Fig. 4(b) . This result contrasts the separation achieved by a PCA model with only one principal component (when the null hypothesis was not rejected by this same test, with p = 0.19), and it therefore supports the two-component model as a compact, but not oversimplified, representation of the sample set.
The information contained in the reduced model (see first two columns in Fig. 4(a) ) has general implications for the study of protein networks. Starting with heterogeneous measurements from a complex signaling network ( Fig. 1(a) ), we created a model that efficiently reduced the dimensional complexity from
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29 to 2 dimensions (Fig. 4(a) ). This reduced model was informative, in that it clearly determined from the differences in protein state (but without any prior knowledge) that the data derived from two sets of cells that had been exposed to different death and survival mediators.
As mentioned in the Introduction, the original measurements themselves contain real biological meaning, it is therefore valuable to explore the contribution of individual signals to the datawide model, as well as the interplay between signals; the relationship between the multivariate models and the original signaling measurements is contained in the loadings matrix. Upon inspection of the loadings, we first found that none of the reduced axes (the principal components) corresponded to an individual measurement (data not shown). Rather, the axes were composed of combinations of measurements: the first principal component points largely toward early, prosurvival signals, such as phosphorylated Akt substrates and phospho-IκB, whereas the second component points more toward late, prodeath signals, such as cleaved and procaspase levels (data not shown). Second, we found that not all measurements were equally informative. As mentioned earlier, high-dimensional data usually contains measurements that are collinear, and we identified several groups of measurements with equally weighted loadings (data not shown), indicating that these signals were redundant in their information content. Importantly, this grouping was consistent with the known biology. For example, the regulatory phosphorylation of Akt and the enzymatic activity of Akt were highly collinear, and the phosphorylation states of many Akt substrates were clustered. Therefore, we can conclude that PCA has achieved an effective data fusion of heterogeneous sources of data.
Overall, our results with PCA suggest that a multivariate, but by no means comprehensive, set of signaling measurements is sufficient to classify phenotypically distinct samples of cells, whereas no single measurement has this power of discrimination. PCA also appears to be effective at fusing diverse data sources into a single consistent model. More generally, the analysis suggests that there exists a set of highly informative measurements that, in combination, compactly describes the relevant variations in signaling network state and might in the future obviate the need to characterize all of the signals in the network.
Identification of survival signals by discriminant partial least squares
Our next step in data analysis focused on attempts to incorporate prior knowledge about cell treatments rather than to derive them post facto. In general, data analysis is much more powerful if prior knowledge can be captured effectively; the specific prior knowledge in our data is that some cells were treated only with TNF-α whereas others were cotreated with insulin. HT-29 cells die in response to TNF-α (Abreu- Martin et al., 1995; Wilson et al., 2002) and are rescued from TNF-induced death when cotreated with insulin (Remacle-Bonnet et al., 2000) . To focus on this death-versus-survival decision, we used PLS, since it is designed to generate data-driven models that relate a matrix, or block, of independent measurements to a block of dependent measurements or classifications.
Cue, signal, and response measurements can act as independent or dependent blocks, but it is conceptually helpful to organize the data so that cause-effect relationships are appropriately directed in relation to the original biological setting (i.e., so that an independent block of signals affects a dependent block of responses, rather than the reverse). In our case, the independent block contains the levels and activities of proteins, and the dependent block contains the binary information on cytokine treatments that constitutes our prior knowledge about the outcome:
• Samples that are associated with cell death (i.e., with TNF-α treatment) ≡ 0.
• Samples that are associated with cell survival (i.e., with TNF-α + insulin treatment) ≡ 1.
For the classification, we assigned time points from each treatment to one of the two classes, ignoring the time component. This class architecture highlights proteins whose state, level, or activity is consistently different between the two responses at all time points. (In future work, we expect to have sufficient data to look at each time point individually.) Since our model is meant to bring out the differences between the two outcome classes, it belongs to a subcategory of PLS called discriminant partial least squares regression (DPLSR).
To perform DPLSR, the original M samples × N measurements data matrix is supplemented with a separate, dependent block of M samples × one classification. Principal components are extracted iteratively from the independent block, analogously to PCA, and the dependent block might also be decomposed, if there were multiple classifications. The most important modification is that, whereas PCA extracts latent variables to maximize the information captured from the independent block, DPLSR decomposes the data matrix to maximize the correlation between the principal components and the (possibly decomposed) classification of the dependent block. The principal components are related to the dependent block by additional coefficients, called weights, that quantify the contribution of each component to the class model through an "inner product."
Whereas PCA generates a reduced model of the variations in the independent block alone, the decomposition criterion for DPLSR focuses on the relationship between the independent and dependent blocks, highlighting the measurements that strongly covary with the known outcome and deemphasizing those that do not. In other words, it is insufficient for a measurement to simply change from sample to sample-to be regarded as significant in the DPLSR model, these changes must covary with the changes in apoptotic response. This is a powerful quality of PLS, since it is frequently difficult to identify the determinative changes in a particular response, when the characteristics of many other proteins are simultaneously varying.
We decomposed our signaling dataset with DPLSR and the aforementioned binary classification system, after preprocessing the independent and dependent block as described earlier. The decomposition criterion makes the data in the original dependent block more valuable than the independent block for assessing information capture, so we concentrated on model capture of the class structure rather than capture of the signaling variation, which was the focus of PCA. As with the PCA model, however, we observed that the first two components were highly informative (78% capture of the class structure) and that information content fell rapidly with increasing component number (data not shown).
To cross-validate the two-component DPLSR model, we first used a Cooman's plot ( Fig. 5(a) ) to determine the ability of the model to discriminate between two samples classes. The abscissa and ordinate mark the deviations of the samples from the two classes. The four quadrants demarcate the samples that, according to the model, would fall into (I) neither class, (II) the death class, (III) both classes, or (IV) the survival class. We see in Fig. 5(a) that the TNF-α samples (diamonds) fall largely in (II) and TNF-α + insulin samples (squares) fall in (IV). Thus, the DPLSR model allows good discrimination of the two outcomes, with only a few samples falling into (III) and no samples in (I). Interestingly, the sample with the largest deviation from the death class (TNF-α + insulin at 30 min, marked by an arrowhead in Fig. 5(a) ), corresponds to the time point at which the largest number of measurements differ in a pairwise comparison of the TNF-α and TNF-α + insulin samples (data not shown).
Although both PLS and PCA reduce data complexity, PLS is generally more powerful because of the predictive ability of the resulting models. After a PLS model has been generated linking independent and dependent blocks, one can attempt to predict which dependent variable is linked to a particular set of measurements. PLS model predictions are achieved in three steps: 1) an experiment is projected onto the reduced principal component space of the PLS model; 2) in this principal component space, the model then uses the inner product, consisting of scores, loadings, and weights, to calculate a predicted dependent component; and 3) if the dependent block has been reduced in the model, the predicted dependent component is recomposed to form a predicted dependent block.
We used this predictive power as an additional form of cross-validation to evaluate how well the PLS model recapitulated the original outcome classes from the independent block of signaling measurements. In Fig. 5(b) , for each sample, we plotted the observed (assigned) class against the class predicted by the DPLSR model using only the independent block of the sample. These predictions were not de novo predictions, since all the data are part of the training set. Nevertheless, these predicted outcome classes do provide an indication of model quality: if the model were to perfectly fit the training set, then all of the TNF-α treated samples would collapse upon (0, 0) and the TNF-α + insulin treated samples upon (1, 1) in the observed-versus-predicted plot. Instead, the data spread laterally from these coordinates, because we retained only two principal components in the PLS model, but we considered the two-component model valid, since it achieved the desired separation of the samples, with no overlap between the two sample classes.
As mentioned before, our original motivation for developing the DPLSR model was to quantify the contributions of various signaling measurements to the outcome classification, and we therefore examined the measurement space of the PLS model. In the PLS model, the contributions of a measurement take the form of a regression coefficient that includes the multiplicative and additive influences of the loadings and scores of the measurement in the two principal components that are retained, along with the weights relating these principal components to the class outcome. The columns in Fig. 6 shows the regression coefficients for all state, level, and activity measurements included in the model. Positive regression coefficients suggest correlations with survival, by contributing to a "1" classification by addition, and negative regression coefficients suggest correlations with death, by contributing to a "0" classification by subtraction.
Next, we assessed the significance of these regression coefficients in the context of the model, the class structure, and the original dataset. Techniques for estimating significance in PLS models vary, but we had success with a Monte Carlo-type strategy, where the rows of the dependent block (here, the classifications) are shuffled randomly, and a DPLSR model is created with a new set of regression coefficients (Rohlf et al., 2000) . These regression coefficients are naïve, since the prior knowledge about the outcome of these samples is lost by the randomization procedure. After several hundred shuffling iterations, one can gain an indication of each mean naïve regression coefficient (usually near zero) in a particular data structure FIG. 6. Discriminant partial least squares regression identifies Akt phosphorylation state, procaspase 8 levels, TNFR1 levels, and Akt activity as important signals for cell survival. The columns represent the model regression coefficients, whereas the points represent the mean naïve coefficient (± S.D.) from 500 block shuffling iterations. The asterisks indicate measurements with regression coefficients outside of those expected by a naïve model. and, importantly, the variation of the regression coefficient about its mean. The results of these shuffling iterations are included as markers in Fig. 6 , with asterisks indicating the seven "outcome classifiers." These measurements have regression coefficients substantially different from the naïve coefficients that would be expected by chance classification.
Most significantly, we found that, despite the simple classifications in the DPLSR model, the multicomponent properties of the apoptosis network were clear (Fig. 7) . When we generated DPLSR models with partial datasets consisting of certain isolated classifiers, such as the levels of TNF receptor 1 (TNFR1, leftmost column in Fig. 7) , we recapitulated the class structure poorly (38% capture). In contrast, with the complete set of outcome classifiers, we generated a model of nearly the same quality as when the entire dataset was used (74% versus 78% capture, compare third and fourth column in Fig. 7) . By this analysis, we identified those signals that the data support as a "minimal model" for predicting the dependent block. Therefore, both the PCA and DPLSR models support the hypothesis that measurement of individual molecules is not sufficient to capture network properties, but an appropriate set of information-rich measurements can, in combination, create useful models of the signaling network.
A number of the survival classifiers found by DPLSR were intuitively reasonable from a biological perspective: Akt phosphorylation state, procaspase 8 level (both forms), and Akt activity. Akt is phosphorylated in response to insulin treatment (Lawlor et al., 2001) , and phosphorylation leads to an increase in catalytic activity (Alessi et al., 1996; Kohn et al., 1996) to constitute a potent prosurvival signal (Dudek et al., 1997) . Caspase 8 is an initiator caspase along one of the death pathways (Nicholson et al., 1997) . Early in the TNF-α time course, the inactive pro-form was processed to the active, cleaved form ( Fig. 2(a) ). In the TNF-α + insulin time course, however, this cleavage was blocked, retaining high levels of the procaspase 8 zymogen (Fig. 2(b) ).
FIG. 7.
A combined subset of critically important survival signals quantitatively captures outcome classes to the same extent as an entire dataset. Smaller subsets of the data were modeled individually by DPLSR and characterized by their ability to capture the death-versus-survival class structure. Note that the dataset consisting of measurements of TNFR1, procaspase 8, and Akt, in combination, captures nearly as much of the assigned class structure as all 29 measurements.
In contrast, it was intriguing and counterintuitive that the model identified the level of expression of TNFR1 as a survival classifier. Comparison of the original time courses showed that the DPLSR result was supported by the original sample set ( Fig. 2(a-b) ), perhaps suggesting that insulin competes with, or inhibits, the internalization and downregulation of these receptors (Kull, 1988) . Alternatively, there may be other potentiating effects of insulin on TNFR1 expression (Dunger et al., 1995) . The identification of TNFR1 levels as a predictor for outcome emphasizes that DPLSR models can incorporate prior knowledge without biasing against novel or counterintuitive signal-response relationships.
In addition to extracting outcome classifiers, the DPLSR model also identified measurements with zero, or near zero, contribution to any class discrimination (e.g., 48 kDa JNK phosphorylation state, total Akt level). Thus, in the same way that PCA filters noise and identifies redundant measurements within a dataset, PLS models deemphasize signals that do not productively contribute to a correlation with the dependent block. This is useful from a practical standpoint, since future experiments can be made more efficient and less costly by eliminating these measurements.
Interestingly, the DPLSR model exclusively highlighted survival classifiers from this set of signaling measurements, with no death classifiers significantly outside of random fluctuations in the data. We believe that failure to identify death classifiers is simply a reflection of the two treatment conditions that generated the samples: TNF-α treatment alone, placed in the death class, and TNF-α + insulin cotreatment, placed in the survival class. Insulin was expected to activate a number of pathways that DPLSR would identify as survival classifiers, but since TNF-α was present as a cue in both the death and survival outcomes, insulin would need to rapidly attenuate a TNF-induced pathway at all time points for the pathway to be highlighted as a death classifier. We expect that our models will extract additional classifiers, as we work toward supplementing the dataset with more diverse cue combinations (e.g., insulin alone, no cytokines).
Exploration of signal-response space by small molecule inhibitors and partial least squares
We hypothesized that data-driven models could be made to efficiently capture signal-response space when cells were treated with small molecules that mimic the action of drugs. We sought to fuse prior knowledge of key pharmacological parameters (namely, the IC 50 of a small molecule) with measurements of the phenotypic effects of these drugs. Small molecule inhibitors of four protein kinases (MEK, JNK, p38, and PI3K) were used in various combinations and concentrations to quantitatively change important kinase activities (see Fig. 1(a) for the position of these kinases in the signaling network), and the effect of these inhibitors on basal, TNF-induced, and TNF-α + insulin-induced cell death in HT-29 cells was measured by flow cytometry using an apoptotic marker (see Materials and Methods). We calculated kinase activities as functions of inhibitor concentration but not cytokine treatment (see equation in top left of Fig. 8(a) and Materials and Methods), thus we treated the three stimulation conditions separately (inhibitors alone, TNF-α with inhibitors, and TNF-α + insulin with inhibitors) to model sample groups that had their kinases activated by the same cytokines. In addition, the models included nonlinear representations of kinase activity as separate measurements to account for synergistic influences of the target kinases on apoptosis (see Materials and Methods).
These nonlinear terms, together with the original calculated activities, were preprocessed and decomposed to generate PLS models for the different cytokine treatments. Figs. 8(b-d) show cross-validated predictions for the models of the three inhibitor datasets compared with measured death. We see that the PLS models capture the dynamic range of the measured dependent block with good correlation (R 2 ∼ 0.6-0.8) between the predicted and observed cell death in the training set, and the models consistently identified a number of signaling activities that contributed positively or negatively to apoptosis. For instance, both p38 activity and the square of p38 activity were assigned strong positive regression coefficients (data not shown), suggesting that this pathway is a hypersensitive prodeath predictor. In contrast, the multiplicative activity of MEK × JNK was a significant prosurvival signal for cells treated with TNF-α or both TNF-α and insulin, implying synergistic regulation of apoptosis by these pathways. These preliminary models indicate that PLS can easily incorporate pharmacological knowledge with experimental data into a coherent model that captures the combinatorial effects of drug treatments on cell response to suggest modes of drug action. It remains to be determined whether this can now be used to design combinations of drugs that will have a synergistic effect on apoptosis.
CONCLUSIONS
Signal transduction in mammalian cells involves the coordinated activities of many proteins. Modeling techniques, such as PLS, developed to explicitly treat multivariate data are helpful tools for gaining insight from large-scale biological experiments. To gain network-level understanding of the cytokine-induced death-versus-survival decision in HT-29 cells, we have applied PLS to a large set of heterogeneous protein measurements from cells treated with the death factor, TNF-α, alone and in combination with the survival factor, insulin. Our goal was to determine the properties of the signaling network that were most determinative for cell survival. We found that heterogeneous data on apoptotic signaling can be reduced, without any prior knowledge, to a PCA model that captures the most salient variations and discards less informative contributions from higher dimensions. This analysis highlights the multicomponent properties of cell signaling and identifies points of redundancy in the dataset.
Additionally, we have found that PLS can filter protein data in a more directed fashion to correlate measurements with cell phenotypes. We used outcome classes and DPLSR-based modeling to identify Akt, caspase 8, and TNFR1 as critical nodes in the signaling network that together act as a reduced set of highly informative network measurements for classifying cell survival. However, no single measurement of a single protein was as informative as the combined set of classifiers. Initial experiments also suggest that it will be possible to incorporate pharmacological data into our models for the purpose of exploring drug action. The predictive and data-fusing capabilities of PLS models suggest that a number of other biological causeeffect relationships might be productively explored with PLS and systematic measurements of underlying signal transduction pathways.
FIG. 8.
Partial least squares regression quantitatively relates inhibitor-induced changes in cell signaling to continuous measurements of cell response. (a) PLS modeling framework for relating dose-response curves of pathway inhibitors to cell function. The inhibitor concentrations were used to calculate an estimated effect on pathway activity (top left) that was then used as an independent block with the measured effects of the inhibitor on cell death (top right) as the dependent block. Each inhibitor was assumed to act specifically on the intended target, with no secondary effects on the other pathways. Column shade represents the magnitude of the different samples in the independent block (bottom left) and dependent block (bottom right). Observed-versus-predicted plots for PLS models of death in response to (b) inhibitors alone, (c) TNF-α in the presence of inhibitors, (d) TNF-α + insulin in the presence of inhibitors. The models included linear and nonlinear signaling activities in the independent block, as described in Materials and Methods. The hatched lines represent what would be expected if there were perfect agreement between the model predictions and the original dataset.
